Colette Hamilton, CEO and Principal Economist, will be providing economic support to the Integrated European Network on Chronic Graft Versus Host Disease (cGvHD), a major cause of non-relapse morbidity and mortality following allogeneic haematopoietic stem cell transplantation.
The network will deliver a programme of projects to accelerate innovation, standardise practice and promote research to identify more cost effective and personalised approaches to the prevention and management of cGvHD. The programme will be delivered by clinical experts, academics and scientists across 17 European countries by 2022.
